Accordingly, future research should extend beyond mere exploration of efficacy and actively advance health economic evaluations, implementation research, and equity-oriented strategy practice
Among other key findings: More than half of employers that cover GLP-1s for weight management expect the expensive medications to yield significant clinical benefits, but few have seen evidence of those (e.g., a reduction in obesity rates, fewer employees needing bariatric surgery) within their aggregated claims

visits during heat wave02:17 | July 7, 2026 Health Matters: European heatwave continues to devastate France02:15 | June 29, 2026 Health Matters: European heat wave causing hospital machines to fail02:08 | June 25, 2026 More than 1,000 confirmed cases of Ebola in DRC01:21 | June 22, 2026 Health Matters: Experts call for more AI safeguards in online safety bill02:20 | June 22, 2026 Health Matters: Judge dismisses bid to stall closure of Alberta supervised drug sites01:42 | June 17, 2026 Health Matters: Britain to ban social media for kids under 1602:31 | June 15, 2026 Health Matters: Quebec bans energy drinks for people under 1602:15 | June 12, 2026 Health Matters: World Cup visitors warned about drug supply02:44 | June 10, 2026 Health Matters: Canadian who tested positive for hantavirus has recovered02:33 | June 9, 2026 Health Matters: Confirmed Ebola cases continue to rise in Congo outbreak02:40 | June 8, 2026 Health Matters: Ottawa tables first national strategy on eye care02:28 | June 5, 2026 Health Matters: Support for MAID law remains high in Canada, Angus Reid survey says02:30 | June 1, 2026 Health Matters: Head of WHO arrives in Congo amid Ebola outbreak01:59 | May 29, 2026 Mental health conditions on the rise in Canada, CIHI report says01:53 | May 28, 2026 Health Matters: Mental health conditions on the rise in Canada, CIHI report02:02 | May 28, 2026 Health matters: Federal health minister announces launch of new drug analysis centre02:24 | May 27, 2026 DRC Treatment hospital attacked during Ebola outbreak02:26 | May 25, 2026 Health Matters: GLP-1 drugs work for weight loss, study finds02:22 | January 7, 2025 Health Matters: West Nile risk increases in Hamilton, Ont.02:04 | July 31, 2026 Health Matters: Health Canada grants injunction against unauthorized peptide producer02:13 | July 30, 2026 Health Matters: Skeeter syndrome cases on the rise in Edmonton02:13 | July 29, 2026 Health Matters: Rexulti class-action lawsuit deadline approaching02:19 | July 27, 2026 Health Matters: PHAC says pistachio salmonella outbreak officially over01:57 | July 22, 2026 Health Matters: FDAs cyclospora investigation into Taylor Farms lettuce continues02:05 | July 21, 2026 Health Matters: Source of U.S

Because retatrutide is still in clinical trials, candidate criteria are based on standard research parameters for metabolic and anti-obesity medications
Serving Size: 1 mL (2 pumps)
Semaglutide and Similar Medications for Weight Loss While semaglutide and other GLP-1 medications are quite effective for weight loss, not everyone is a suitable candidate for them